Kevin Tang
Chief Executive Officer at JOUNCE THERAPEUTICS, INC.
Profile
Kevin C.
Tang is the founder and currently holds the position of President at Tang Capital Management LLC, which was founded in 2002.
He was also the founder and held the position of Independent Director at Ardea Biosciences, Inc., which was founded in 1994.
Mr. Tang's current job(s) include being the Chief Executive Officer & Director at Jounce Therapeutics, Inc., Chairman & Chief Executive Officer at Odonate, Inc., Chief Executive Officer at Concentra Biosciences LLC, and Director at Tetraphase Pharmaceuticals, Inc.Mr. Tang's former job(s) include being the Chairman at Heron Therapeutics, Inc. from 2012 to 2020, Chairman at La Jolla Pharmaceutical Co. from 2014 to 2022, Director at Trimeris, Inc. from 2001 to 2008, Director at Penwest Pharmaceuticals Co. in 2010, Managing Director at Cash Reserve Fund, Inc. from 1993 to 2001, Director at ACLARA Biosciences, Inc., Director at IntraBiotics Pharmaceuticals, Inc., Managing Director & Head-Life Sciences Research at Deutsche Bank Alex.
Brown, Inc. from 1993 to 2001, Director at RadPharm, Inc., Director at Prospect Therapeutics, Inc., and Head of Life Sciences Research Group at Deutsche Bank Securities, Inc. from 1993 to 2001.
Mr. Tang obtained his undergraduate degree from Duke University in 1989.
Kevin Tang active positions
Companies | Position | Start |
---|---|---|
ODONATE, INC. | Chief Executive Officer | 2012-12-31 |
TETRAPHASE PHARMACEUTICALS, INC. | Director/Board Member | 2020-07-27 |
JOUNCE THERAPEUTICS, INC. | Chief Executive Officer | - |
Concentra Biosciences LLC
Concentra Biosciences LLC BiotechnologyHealth Technology Concentra Biosciences LLC is a bioscience company. The private company is based in San Diego, CA and has subsidiaries in the United States. The CEO of the company is Kevin C. Tang. | Chief Executive Officer | - |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Chief Executive Officer | 2002-07-31 |
Former positions of Kevin Tang
Companies | Position | End |
---|---|---|
LA JOLLA PHARMACEUTICAL COMPANY | Chairman | 2022-08-21 |
HERON THERAPEUTICS, INC. | Chairman | 2020-08-03 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Founder | 2012-05-31 |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Chairman | 2010-08-31 |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Kevin Tang
Duke University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
HERON THERAPEUTICS, INC. | Health Technology |
ODONATE, INC. | Health Technology |
Private companies | 15 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Cash Reserve Fund, Inc.
Cash Reserve Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Cash Reserve Fund, Inc. operates as an open-end investment fund trust. The fund offers prime, treasury and tax-free series. The fund was established in 1990 and is headquartered in New York, NY. | Miscellaneous |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital Management LLC (Tang Capital) is an independent hedge fund manager headquartered in San Diego, California. The firm was founded by Kevin Tang in 2002. Tang Capital provides investment advice to high-net-worth clients. | Finance |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Deutsche Bank Alex. Brown, Inc.
Deutsche Bank Alex. Brown, Inc. Financial ConglomeratesFinance Deutsche Bank Alex Brown, Inc. provides wealth management services. The company was founded in 2000 and is headquartered in Baltimore, MD. | Finance |
RadPharm, Inc.
RadPharm, Inc. Medical/Nursing ServicesHealth Services RadPharm is a leading imaging core lab, managing the complete imaging segment of clinical trials for the global pharmaceutical, biotechnology and medical device industries. With greater than 16 years experience supporting over 350 clinical trials, across 60 countries and 6,000 unique sites, RadPharm's vast expertise spans early stage through phase IV studies and all major therapeutic areas. In addition to having a specialty in oncology trials, they also possess deep experience with cardiovascular, musculoskeletal, CNS, diagnostic contrast imaging agents and medical device studies. RadPharm employs board-certified, sub-specialty trained radiologists, nuclear physicians and medical oncologists, uniquely positioning us to focus on the Medicine Behind the ImageTM. Its experienced medical staff interprets data from all major modalities, including, but not limited to, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-ray, Single Photon Emission Computed Tomography (SPECT), Ultrasound, Positron Emission Tomography (PET) and PET/CT. They provide centralized, independent, unbiased interpretation of medical images for clinical trials, integrated with a proven planning, tracking and implementation process specifically designed to exceed your expectations and timelines. RadPharm speeds delivery of your product to market by supporting your trial program with medical expertise, regulatory know-how and advanced, validated technologies. RadPharm, Inc. provides oncology and medical imaging review services. It also offers radiation therapy QA services, oncology clinical reviews, and complete medical photography services. The company was founded in 1998 by Robert Ford and is headquartered in Princeton, NJ. | Health Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
Prospect Therapeutics, Inc.
Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Prospect Therapeutics, Inc. develops biopharmaceuticals to treat variety of cancers. The firm's products include GCS-100, for the treatment of leukemia, multiple myeloma and lymphoma, GCS-100, a proprietary polysaccharide, targets galectin-3, a protein over-expressed in cancer cells that promotes their survival, proliferation and metastasis. The company was founded by Joseph Grimm, George Tidmarsh, and Kevin Tang in July 2006 and is headquartered in Woburn, MA. | Health Technology |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Concentra Biosciences LLC
Concentra Biosciences LLC BiotechnologyHealth Technology Concentra Biosciences LLC is a bioscience company. The private company is based in San Diego, CA and has subsidiaries in the United States. The CEO of the company is Kevin C. Tang. | Health Technology |
- Stock Market
- Insiders
- Kevin Tang